Top Page
Wide Open Agriculture Ltd.
(Sydney:WOA)
Wide Open Agriculture Ltd. (WOA) vs. iShares MSCI Australia ETF (EWA)
Wide Open Agriculture Ltd. Business Overview & Revenue Model
Wide Open Agriculture Ltd. Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 468.87K | 468.87K | 73.13K | 210.00 | 9.26M | 4.32M |
| Gross Profit | -338.00K | -338.00K | -1.79M | -7.87M | -5.94M | -2.22M |
| EBITDA | -5.16M | -5.16M | -8.53M | -13.86M | -10.06M | -7.73M |
| Net Income | -7.09M | -7.09M | -13.25M | -14.66M | -10.79M | -7.53M |
Balance Sheet | ||||||
| Total Assets | 8.38M | 8.38M | 10.78M | 15.40M | 29.58M | 17.49M |
| Cash, Cash Equivalents and Short-Term Investments | 3.39M | 3.39M | 2.45M | 5.87M | 19.47M | 12.98M |
| Total Debt | 846.98K | 846.98K | 1.86M | 2.71M | 3.16M | 2.14M |
| Total Liabilities | 2.31M | 2.31M | 3.53M | 5.29M | 5.60M | 3.37M |
| Stockholders Equity | 6.07M | 6.07M | 7.25M | 10.11M | 23.98M | 14.11M |
Cash Flow | ||||||
| Free Cash Flow | -3.50M | -3.50M | -9.18M | -13.31M | -12.48M | -6.05M |
| Operating Cash Flow | -3.49M | -3.49M | -8.55M | -11.87M | -10.17M | -5.71M |
| Investing Cash Flow | 84.10K | 84.10K | -4.99M | -1.43M | -2.42M | -244.22K |
| Financing Cash Flow | 4.34M | 4.34M | 10.15M | -319.08K | 19.08M | 14.50M |
Wide Open Agriculture Ltd. Technical Analysis
Wide Open Agriculture Ltd. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Neutral | AU$17.69M | 9.06 | 14.00% | ― | 18.35% | 55.88% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | AU$68.08M | 9.77 | 29.12% | ― | 2.63% | ― | |
55 Neutral | AU$124.50M | 12.42 | 8.91% | ― | 4.34% | ― | |
54 Neutral | AU$44.51M | 60.24 | -11.46% | 24.37% | -16.73% | -343.82% | |
46 Neutral | AU$1.23M | ― | -130.24% | ― | 17.85% | 52.81% | |
45 Neutral | €13.09M | ― | -122.46% | ― | -94.79% | 82.57% |
Wide Open Agriculture Ltd. Corporate Events
Wide Open Agriculture Ltd. reported a significant increase in lupin protein sales, with a 226% rise quarter-on-quarter, supported by repeat orders from customers across various regions. The company is strategically expanding its German facility to double production capacity with minimal investment, and it has signed an exclusive distribution agreement with Univar Solutions to enter the Chinese market. A recent capital raise of $2.6 million will accelerate this market entry and boost sales. The company’s lupin protein isolate is gaining traction in the market, achieving premium pricing and being benchmarked against established proteins like whey.
Wide Open Agriculture Ltd announced a change in the director’s interest, with Yaxi Zhan acquiring 434,783 fully paid ordinary shares and 217,392 listed options through participation in a Tranche 2 placement. This acquisition, approved by shareholders, reflects the company’s ongoing strategic initiatives to strengthen its market position and enhance shareholder value.
Wide Open Agriculture Ltd. has issued 1,956,523 fully paid ordinary shares and 56,413,047 listed options as part of their recent capital raising efforts. This move is in compliance with relevant sections of the Corporations Act, indicating the company’s strategic steps to enhance its financial position and potentially expand its market presence.
Wide Open Agriculture Ltd has announced the issuance of 5,000,000 unlisted options, exercisable at $0.05 each and expiring on July 11, 2027. This move is part of a previously announced transaction and reflects the company’s strategic financial maneuvers to enhance its market position and operational capabilities.
Wide Open Agriculture Ltd has announced the quotation of new securities on the Australian Securities Exchange (ASX), including 60,378,891 options expiring on July 19, 2026, and 9,888,194 fully paid ordinary shares. This move is part of previously announced transactions and is expected to enhance the company’s financial flexibility, potentially strengthening its market position and offering new opportunities for stakeholders.
Wide Open Agriculture Ltd has successfully closed its Securities Purchase Plan, raising $182,428 through valid applications for 7,931,671 shares, along with issuing free attaching options. The company also received shareholder approval to raise an additional $45,000 through a Tranche 2 Placement, with securities to be issued on 11 July 2025. This financial maneuver strengthens the company’s capital base, potentially enhancing its market position in the plant-based protein sector.
Wide Open Agriculture Ltd announced that all resolutions at their General Meeting were passed without amendment, indicating strong shareholder support for their strategic initiatives. This outcome may enhance the company’s operational capabilities and strengthen its market position, potentially benefiting stakeholders by aligning with sustainable growth objectives.
Wide Open Agriculture Ltd. has announced the closing of its Securities Purchase Plan (SPP) on 7 July 2025, offering eligible shareholders the opportunity to purchase new shares and options without additional transaction costs. Additionally, the company will host an investor webinar on 2 July 2025, where CEO Matthew Skinner will present updates on the company’s progress and future plans, providing stakeholders with insights into its strategic direction.
Wide Open Agriculture Ltd. has announced its position as a global first-mover in the production of lupin protein isolate, emphasizing its superior functionality and sustainability. This advancement positions the company as the largest producer globally, with significant commercial traction in various health-focused markets, potentially impacting its industry standing and offering new opportunities for stakeholders.
Wide Open Agriculture Ltd. has announced an upcoming investor webinar scheduled for 2 July 2025, where CEO Matthew Skinner will present an updated Investor Presentation. This event provides an opportunity for stakeholders to gain insights into the company’s strategic direction and engage with the leadership through a Q&A session, potentially impacting investor confidence and market positioning.
Wide Open Agriculture has successfully completed a manufacturing trial for its BP80F lupin protein production process, showcasing significant efficiency improvements. The trial, conducted in the USA with commercial-scale equipment, demonstrated up to 80% reduction in energy consumption and a 50% reduction in processing time, indicating a more scalable and cost-effective production process. These advancements enhance the protection of WOA’s proprietary technology and suggest potential improvements in operating and capital expenditures for current and future facilities.
Wide Open Agriculture Ltd has announced the quotation of 1,000 ordinary fully paid securities on the ASX, effective June 12, 2025. This move reflects the company’s ongoing efforts to enhance its market presence and provide value to its stakeholders by leveraging financial instruments to support its growth and operational strategies.
Wide Open Agriculture Ltd. has announced the successful initial trials of a novel lupin oil extraction process, which preserves the oil’s natural nutrients and bioactive compounds. This new method is cost-effective, requiring less energy and capital expenditure compared to existing processes. The lupin oil, with its antioxidant, moisturizing, and anti-inflammatory properties, is poised to enter the global cosmetics market, potentially increasing revenue and reducing waste. The company plans larger scale trials and aims to incorporate these findings into a feasibility study for commercial production, enhancing its market position and operational efficiency.
Wide Open Agriculture Ltd has announced the opening of its Securities Purchase Plan (SPP Offer), which includes a free attaching listed option for every two SPP shares subscribed. This initiative is part of the company’s strategy to strengthen its financial position and support its growth in the plant-based protein market, potentially enhancing its industry standing and providing value to its stakeholders.
Wide Open Agriculture Ltd. has announced a Share Purchase Plan (SPP) for its shareholders in Australia and New Zealand, allowing them to purchase up to $30,000 worth of new shares at $0.023 per share. Participants will also receive a free option for every two shares purchased, exercisable at $0.030 each, expiring in July 2026. This initiative aims to strengthen the company’s capital base and potentially enhance its market position by engaging existing shareholders in its growth strategy.
Wide Open Agriculture Ltd has announced a security purchase plan (SPP) offering up to 21,739,130 shares at $0.023 per share, along with up to 10,869,565 options, to raise up to $500,000. This move is aimed at strengthening its financial position and enhancing its market presence, although the offer is not underwritten, indicating potential risks for investors.
Wide Open Agriculture Ltd has announced a General Meeting of shareholders scheduled for July 3, 2025, at their Leederville, WA office. This meeting will address various resolutions, with shareholders encouraged to participate either in person or via proxy voting. The company emphasizes the importance of the Notice of Meeting and advises shareholders to consult professional advisors if needed.
Wide Open Agriculture Ltd has announced the quotation of 110,869,565 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of May 15, 2025. This move is part of a previously announced transaction, potentially impacting the company’s market presence and offering stakeholders an opportunity to engage with its growth strategy.
Wide Open Agriculture Ltd. has announced a successful capital raising of $2.6 million through a placement, with plans to raise an additional $500,000 via a Share Purchase Plan. The funds will be utilized to accelerate the company’s market expansion, particularly targeting the Chinese market, and to further commercialize its lupin protein isolate, which has already seen initial global sales.